Similar Clinical Severity and Outcomes for Methicillin-Resistant and Methicillin-Susceptible Pediatric Musculoskeletal Infections.

Background: Prior studies of pediatric musculoskeletal infection have suggested that methicillin-resistant (MRSA) infections result in worse outcomes compared with infections with methicillin-susceptible (MSSA) strains. Based on these results, clinical prediction algorithms have been developed to differentiate between MRSA and MSSA early in a patient's clinical course. This study compares hospital outcomes for pediatric patients with MRSA and MSSA musculoskeletal infection presenting to the emergency department at a large tertiary care children's hospital.

Methods: A retrospective study identified pediatric patients with musculoskeletal infection over a 5-year period (2008-2013) by sequential review of all pediatric orthopedic consults. Relevant demographic information, laboratory values, and clinical outcomes were obtained from the electronic medical record.

Results: Of the 91 identified cases of pediatric musculoskeletal infection, there were 49 cases of MRSA infection (53%) and 42 cases of MSSA infection (47%). There were no significant differences between MRSA and MSSA infections in median hospital length of stay (4.8 vs 5.7 days, = .50), febrile days (0.0 vs 1.5 days, = .10), and antibiotic duration (28 vs 34 days, = .18). Methicillin-resistant infections were more likely to require operative intervention than MSSA infection (85% vs 62%, = .15). A logistic regression model based on C-reactive protein, temperature, white blood cell count, pulse, and respiratory rate at presentation demonstrated poor ability to differentiate between MRSA and MSSA infection.

Conclusions: The results demonstrated no significant differences between MSSA and MRSA musculoskeletal infections for most hospital outcomes measured. However, MRSA infections required more operative interventions than MSSA infections. In addition, a predictive model based on severity markers obtained at presentation was unable to effectively differentiate between MRSA and MSSA infection. The clinical utility and capacity for early differentiation of MRSA and MSSA depends on virulence patterns that may vary temporally and geographically.